Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immune Therapeutics Inc
(OP:
IMUN
)
N/A
UNCHANGED
Last Price
Updated: 12:27 PM EDT, Oct 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Immune Therapeutics Inc
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky
September 14, 2023
From
Immune Therapeutics, Inc.
Via
GlobeNewswire
Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV
August 29, 2023
From
Immune Therapeutics, Inc.
Via
GlobeNewswire
Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH
August 15, 2023
From
Immune Therapeutics, Inc.
Via
GlobeNewswire
Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies
April 20, 2023
The settlement between Statera Biopharma, Inc. and Biostax Corp. includes an amended royalty-bearing license agreement and a joint petition to dismiss the involuntary bankruptcy case against Statera...
From
Immune Therapeutics, Inc.
Via
GlobeNewswire
Immune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Direction
March 01, 2023
From
Immune Therapeutics, Inc.
Via
GlobeNewswire
Immune Therapeutics, Inc. Announces Management Change; Moves Forward with Repositioning Strategy and Long-acting TLR4 (Toll Like Receptor 4) Antagonist JKB-122 Development
November 09, 2022
From
Immune Therapeutics, Inc.
Via
GlobeNewswire
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
September 27, 2022
From
Immune Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.